Science Market Update

CU Anschutz, Sciences Institute awarded $46.5M Grant from NIH

Posted by Gloria Beverage on Fri, Jul 06, 2018

Colorado University Anschutz Medical Campus and its partner, Colorado Clinical and Transitional Sciences Institute (CCTSI), recently received a new five-year $46.5 million grant from the National Institute of Health (NIH).

“The general public may not know the CCTSI name,” Dr. Sokol, CCTSI director and professor of pediatrics in the School of Medicine, stated in an article for CU Anschutz Today. “But they have probably benefited from the research that has come out of our institute over the past 10 years.”

Since its inception, Institute staff have conducted research that has led to a cure for hepatitis C; developed treatments for cystic fibrosis; boosted the rates of health screenings in underserved Colorado communities; and developed community-based approaches to teaching CPR.  

Read More

Tags: 2018, BioResearch Product Faire Event, life science market, direct access to researchers, life science equipment sales, University of Colorado Anschutz Medical Campus, Colorado, Fitz, NIH grants, nih research funding, clinical and translational research funding

$3.8M DOD Grant to U Colorado Moves Stem Cell Research to Clinical Trials

Posted by Gloria Beverage on Mon, Jun 25, 2018

A $3.8 million award from the U.S. Department of Defense (DOD) gives researchers at the Gates Center for Regenerative Medicine on the University of Colorado Anschutz Medical Center campus the opportunity to move into the manufacture of stem cell-created skin grafts.

Read More

Tags: 2018, BioResearch Product Faire Event, life science market, direct access to researchers, life science equipment sales, University of Colorado Anschutz Medical Campus, Colorado, Dental Public Health, Fitz, stem cell science

CU Anschutz Receives 5-Year, $46.5 Million NIH Grant

Posted by Leo Zlimen on Wed, May 30, 2018

The University of Colorado Anschutz Medical Center has been awarded a five-year, $46.5 million NIH grant to continue groundbreaking research programs at its Colorado Clinical and Translational Science Institute (CCTSI).

Read More

Tags: 2018, NIH funding, BioResearch Product Faire Event, life science market, direct access to researchers, life science equipment sales, University of Colorado Anschutz Medical Campus, Colorado

Colorado Researchers Receive $5.5M to Study Cannabis and Genetics

Posted by Laura Braden on Thu, Feb 22, 2018

With cannabis becoming more accepted and legal in different parts of the United States, research institutions around the country are obtaining funding to conduct research into cannabis for medical use. Institutions like the University of California, Los Angeles and the University of Illinois, Chicago have recently received funding to support this type of research. Colorado, one of the states that has legalized cannabis, has been working on obtaining funding for researchers to study the use of this drug. In 2014, researchers across the state were waiting to receive funding for 8 medical marijuana studies. More recently, researchers at the University of Colorado received $5.5 million to research the heath effects of medical marijuana. (Image courtesy of Dinesh Valke via Wikimedia Commons)

Read More

Tags: 2018, UCO, Fitz, Colorado, University of Colorado Anschutz Medical Campus, University of Colorado, cannabis research

UC Anschutz Expands With Gates Biomanufacturing Facility

Posted by Robert Larkin on Thu, Jun 16, 2016

Blog updated on 6/14/2016.

(Image Courtesy of Wikimedia Commons & Jeffrey Beall)

The University of Colorado Medical Campus is a prominent research institution that is expanding even further with last years' opening of the new Gates Biomanufacturing Facility (GBF).

Read More

Tags: Medical Research, Anschutz Medical, University of Colorado Anschutz Medical Campus, BioResearch Product Faire Event, CO, Colorado, new medical buildings, Fitz, Aurora, 2016

Colorado Researchers Make Breakthrough on Type I Diabetes

Posted by Cat Girton on Wed, Apr 13, 2016

Diabetes encompasses a group of metabolic disorders that result in chronically elevated blood sugar levels. If untreated, these diseases can result in serious complications such as ketoacidosis, heart disease, kidney failure, and stroke. The most common type of diabetes is type II diabetes, which accounts for 90-95% of cases (a recent Philadelphia study helped us gain further insight into why type II diabetes occurs). The incidence of type I diabetes is much lower, accounting for just 5-10% of cases. However, while type II diabetes can resolve on its own with changes in diet and exercise habits, type I is considered incurable. Now, a new study from the University of Colorado, Anschutz Medical Campus has identified a new class of antigens that may be a factor in the development of the disease.

Read More

Tags: Diabetes, University of Colorado Anschutz Medical Campus, autoimmune disease, insulin resistance, lab supplies, Research, Type 1 Diabetes, life science tradeshows, T Cells

University of Colorado Bioresearchers Work to Make Cataract Surgery Safer and More Efficient

Posted by Laura Braden on Wed, Apr 01, 2015

Nearly everyone in the world knows someone who has cataracts or will get cataracts themselves sometime in life. Cataracts, the most common cause of vision impairment, cloud the lens inside the eye and make it difficult to see.  Although surgery can be performed to replace the clouded lens in the eye, it is both costly and challenging for surgeons to perform. (Image of eye by 8thstar via Wikimedia Commons). 

Read More

Tags: University of Colorado Boulder, University of Colorado Anschutz Medical Campus, 2015, BioResearch Product Faire Event, CO, Colorado, Boulder, UCO, Fitz, Cataracts, New surgical device

University of Colorado Receives $1.5 Million for Bone Pathology Research

Posted by Laura Braden on Tue, Feb 10, 2015

In 1930 when Doctor Samuel Fosdick Jones retired from his medical practice and teaching at the University of Colorado, the field of bone pathology research was new and emerging. In order to help support this research area, he set up a trust fund that, years after his death, would grant the University of Colorado funding to use in support of this research field. (Image courtesy of Wikimedia Commons).

Read More

Tags: Southwest, University of Colorado Anschutz Medical Campus, 2015, BioResearch Product Faire Event, CO, new funding, Fitz, Aurora, Orthopedics, bone pathology

CU Anschutz Receives Record Breaking $772 Million in Private Support

Posted by Katheryn Rein on Mon, Nov 25, 2013

The University of Colorado has announced an outstanding $1.521 billion in funding from the private sector through their Creating Futures fundraising project. This effort, CU's 4th fundraising campaign, began quietly in July 2006 and was publically announced in April 2011 after over $900 million had been raised through the generosity of over 115,000 sources. Since the campaign went public, the university has broadened its target audience to include CU alumni and even more individuals relevant to CU's campaign efforts. As of September 30th, CU had received a total of over $1.5 billion, with $722 million going to CU Anschutz Medical Campus and $84 million going to CU Denver. 

Read More

Tags: Colorado, Southwest, Anschutz Medical, CO, University of Colorado, BioResearch Product Faire Event, Denver, 2014, CU, University of Colorado Anschutz Medical Campus, Fitz

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News